Nephron Research Pharma Pricing & Benefit Management Symposium – April 10th in NYC

Often imitated, never duplicated.

Today, the comment period closes on the Trump administration’s proposal to transform the current pharma rebate price system.¬† With that in mind, we think it timely to convene a broad array of manufacturers, benefit managers, payers, and policy experts in New York City on Wednesday, April 10th for Nephron Research’s Pharma Pricing & Benefit Management Symposium.

Building on last year’s success, Michael Kleinrock of IQVIA will kick off the annual event with an examination of gross-to-net, to be followed by a series of industry panels exploring the impact of moving to a discount system on pharmaceutical expenditures, manufacturer commercialization strategies and supply chain economics.

Other highlights of the day include a keynote presentation by the Director of the UPMC Center for Value Based Purchasing responsible for a pioneering value-based contract with AstraZeneca as well as a panel discussion with the leaders of the National Drug Purchasing Coalition responsible for the development of an innovative new PBM model with Express Scripts.

For more information, please email